A decade of varicella screening within a paediatric inflammatory bowel disease population

Rachel E. Harris (Lead / Corresponding author), Lee Curtis, Vikas Hegde, Vikki Garrick, Lisa Gervais, Lawrence Armstrong, Caroline Delahunty, Andrew Eccleston, Ghassan Al-Hourani, Diana M. Flynn, Victoria Merrick, Andrew R. Barclay, Rachel Tayler, Richard Hansen, Richard K. Russell

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)

    Abstract

    Introduction: Increased risk of opportunistic infection-e.g., varicella zoster infection-secondary to therapies is a cause of morbidity in inflammatory bowel disease [IBD] patients. The UK vaccination schedule does not include varicella immunisation. We aimed to evaluate the varicella screening and immunisation programme in a paediatric IBD population. 

    Methods: Data regarding IBD diagnosis, varicella status, and consequent immunisations/treatment interventions were collected retrospectively from the records of patients diagnosed with IBD over a 10-year period [2009-2018]. 

    Results: In all, 520 IBD patients were diagnosed; 505/520 [97%] had varicella testing; 46/505 [9%] were naïve. Of 501 patients, 391[78%] were tested before or within 7 days of diagnosis; this increased in the second 5-year period compared with the first (229/268 [85%] versus 162/233 [70%]; p <0.00001). Median diagnosis age of naïve patients was lower [8.3 years versus 12.8 years; p <0.00001]. Where vaccination was feasible, 21/31 [68%] had two and 7/31 [23%] one immunisation. Prednisolone induction led to lower rates of vaccination (5/13 [39%] versus 23/33 [70%] for other induction therapies; p =0.02). Of 28 vaccinated patients, 5 [18%] had suspected breakthrough varicella; and 6/18 [33%] unimmunised patients required post-exposure prophylaxis or treatment for varicella. Immunisation was associated with a decrease in patients requiring post-exposure prophylaxis (0/28 [0%] versus 5/18 [28%]; p =0.0006) and varicella-related hospital admission (1/28 [4%] versus 4/18 [22%]; p =0.01). 

    Conclusions: High rates of varicella screening and immunisation within a PIBD population are possible, resulting in a reduction in hospital admissions for varicella treatment. Varicella immunisation may be of increasing importance within the PIBD population with the emergence of novel therapeutic strategies.

    Original languageEnglish
    Pages (from-to)608-616
    Number of pages9
    JournalJournal of Crohn's and Colitis
    Volume14
    Issue number5
    Early online date31 Dec 2019
    DOIs
    Publication statusPublished - May 2020

    Keywords

    • immunisation
    • Inflammatory bowel disease
    • varicella zoster virus

    ASJC Scopus subject areas

    • Gastroenterology

    Fingerprint

    Dive into the research topics of 'A decade of varicella screening within a paediatric inflammatory bowel disease population'. Together they form a unique fingerprint.

    Cite this